Two Years After Declining Adjuvant Chemotherapy, Feeling Fine: What 'No Symptoms' Does and Doesn't Tell You — and How to Keep Surveillance on the Calendar

After surgery for colon or rectal cancer, a pathology report showing lymph node involvement usually leads to a conversation about adjuvant chemotherapy. That conversation does not always end with treatment. Some people have lost a great deal of weight, some have other illnesses, and some simply decide not to proceed. When a year or two then passes without obvious problems, two feelings tend to arrive together: relief, and doubt. This article does not argue that either decision is the right one. It separates what 'feeling fine right now' actually means from what it does not.

1. Why the answer sounds uncertain
People often ask whether chemotherapy will cure them, or what happens if they skip it, and receive an answer that sounds evasive. It usually is not. Adjuvant chemotherapy does not target a visible mass; it targets the possibility of minimal residual disease — microscopic cancer cells that no scan or blood test can detect after surgery. Its purpose is to lower the probability of recurrence. It cannot guarantee cure for an individual, and skipping it does not guarantee recurrence. Honest answers to these questions are therefore expressed as probabilities drawn from groups of patients, applied cautiously to one person.

2. Absence of symptoms is a different axis from absence of disease
Recurrent disease can be silent for a long time, and feeling well is not evidence that nothing is there. Body sensation and test results do not substitute for each other. In locally advanced colorectal cancer, the first few years after surgery are the period when recurrence is most often detected, so gaps in follow-up during that window are exactly the gaps that matter later. Two uneventful years are genuinely valuable — but what documents them is a recorded test, not a feeling.

3. 'Too weak now' is not the same as 'never'
Deciding that a body at a low weight cannot tolerate full-intensity chemotherapy is a reasonable clinical concern. But performance status is not a fixed number; it changes with nutrition, strength, pain control, and correction of anemia. In practice the choice is often not all-or-nothing — single-agent regimens, reduced doses, or a delayed start are sometimes discussed. It is worth knowing, however, that adjuvant chemotherapy is generally considered most meaningful when started within a defined window after surgery. Once considerable time has passed, the same drugs carry a different purpose and a different expectation. Ask about this directly if you are reconsidering.

4. The pathology report is the document a decision rests on
Two people with the same stage may receive different recommendations. Worth locating on the report: depth of invasion (pT), number of positive nodes and total nodes examined (pN), margin status, lymphovascular and perineural invasion, and microsatellite instability (MSI) or mismatch repair deficiency (dMMR) status. These items shape both recurrence risk and how much a given treatment is expected to help — useful whether you keep your decision or revisit it.

5. Pausing treatment is not pausing surveillance
Choosing not to have chemotherapy and choosing to be monitored sit on separate axes. Follow-up after colorectal cancer surgery typically combines clinical review, CEA tumor marker blood tests, CT of the chest, abdomen and pelvis, and colonoscopy at set intervals for several years. Rectal cancer adds attention to local pelvic recurrence, and if the whole colon could not be examined before surgery, a colonoscopy is often scheduled relatively early afterward. Exact intervals depend on stage, surgery, and other conditions, so confirm the schedule your own team has set.

6. Changes worth reporting between visits
A clear change in bowel habit, blood in the stool, or persistently narrowed stools. Unintentional weight loss that continues. Abdominal, rectal, or tailbone pain that persists at night. New breathlessness, a dry cough, jaundice, or leg swelling. These have many possible causes, but they are better raised early than saved for the next scheduled visit. A dated one-line note makes the conversation far more precise.

7. What to prepare before the next appointment
Get a copy of the surgical pathology report and mark the items above. Write your tests and their dates on a single page in order. Check when your last CEA, CT, and colonoscopy were, and put the next ones on a calendar. Weigh yourself weekly under the same conditions and keep the trend. Write down three questions — for example, whether adjuvant chemotherapy still has a role at this point, which findings raise your recurrence risk, and which tests you should have at what intervals from here.

8. On mindset
Eating what you want and going where you want matters for quality of life, and excessive restriction can harm both nutrition and mood. Still, a positive outlook supports a person through treatment rather than replacing it — and if an outcome is difficult, that is not a failure of attitude. A decision made once is a door that can be opened again, and what opens it is a record and a booked appointment, not regret.

This article is general information and does not replace individual medical advice. Decisions about treatment and follow-up intervals depend on stage, pathology, general condition, and other illnesses; please discuss them with your own medical team.